Stem Cell Banking Market Widespread Research and Fundamental study to 2026

Stem Cell Banking Market To Receive
Overwhelming Hike In Revenues By 2026
Stem Cell Banking Market, by Source Type (Cord Blood and Cord Tissue), by
Service Type (Collection and Transportation, Processing, Analysis and Storage),
by Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia
and Others), and by Region - Global Trends, and Forecast to 2025
Increasing incidences of chronic disease and the effectiveness of stem cell therapy in the treatment of
such diseases is a major driving factor for growth of stem cell banking market. According to the survey
by Seattle Children’s Hospital and Research Center, 2013, the survival rate of patient with cancer after
stem cell transplant for period of one year was 84% globally. Growing public awareness for stem cell
storage is also contributing to stem cell banking market growth. Additionally, new clinical trial data
that supports applications for hematopoietic stem cells from mesenchymal stem cells and cord blood is
expected to help in growth of stem cell banking market. Moreover, various organizations are supporting
stem cell banking, which is expected to aid in growth of the market. For instance, in 2012, Harvard
University and University of Cambridge announced plans to set up a new stem cells research center,
funded by Medical Trust UK and UK Medical Research Council, to conduct research on stem cells and
their potential to treat a range of life-threatening conditions.
The global stem cell banking market was valued at US$ 1,634.7 million in 2016 and is expected to
exhibit a robust CAGR of 18.9% over the forecast period (2017–2025).
Get The PDF Brochure of This Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1354
High therapeutic potential of stem cells for treating genetic diseases is expected to aid in growth
of the market
High potential of cord blood and tissues for the treatment of patients with autoimmune diseases is
expected to propel the market growth. Moreover, currently available immunosuppressive agents such
as steroids, induce long term side effects despite temporary improvements. According to the Health
Research Funding, 2015, around 28% of cord blood transplants have been used to treat genetic
diseases, with the most common genetic disease treated being severe combined immune deficiency,
followed by aplastic anemia. According to the National Cord Blood Program, 2015, cord blood from
unrelated donors has been used as an alternative to bone marrow or mobilized stem cells, as a source of
hematopoietic stem cells, with over 35,000 stem cell transplants successfully performed worldwide.
Stem cells can be stored indefinitely and can easily retain viability even after a decade of storage and
this is a major factor driving growth of the market. A study of cord blood stem cells conducted at
Indiana University in 2016 demonstrated its viability after 23.5 years of cryogenic storage. Moreover,
increasing awareness about stem cell preservation and significance in treating life-threatening diseases
has led to increasing demand for of stem cell collection and preservation techniques, thus bolstering the
market growth.
Major players operating in the global stem cell banking market are Allergan, Plc., Galderma S.A.,
Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech
Inc., Sinclair Pharma Plc., Suneva Medical, Valeant Pharmaceuticals International, Inc., and Anika
Therapeutics,
Inc.
Asia Pacific is expected to exhibit significant growth in the global stem cells banking market over the
forecast period. This is owing to rising birth rates coupled with increasing prevalence of birth defects,
and options of paying for stem banking in monthly instalments, making it accessible to a number of
people. For instance, according to the survey by Save the Children India, 2012, India has a booming
birth rate of 26 million per year and this is aiding in growth of the market. According to Multicenter
Study, 2013, about 10,000 to 15,000 infants are diagnosed suffering from thalassemia and sickle cell
anemia in India, indicating high demand for stem cells banking.
Ask For Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/1354
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

Stem cells have the potential to transform to any tissue or organ in the body. Stem cells can be found in bone marrow, fetal tissues, baby teeth, fat, human embryos, hair follicles, muscle, and circulating blood, however, cord blood is an effective source of stem cells.